Table 1.
Comparison of the treatment and the control groups that had deep anterior lamellar keratoplasty.
| Parameter | Treatment group (intracameral air) | Control group (non-intracameral air) | Difference | p-value | 95% Confidence interval |
|
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| BCVA (LogMAR) | 0.36 ± 0.36 | 0.17 ± 0.11 | +0.19 | 0.810 | −0.03 | 0.42 |
| Sphere (D) | −5.14 ± 4.17 | −1.02 ± 3.29 | −4.12 | 0.011 | −7.20 | −1.04 |
| Cylinder (D) | −3.16 ± 2.20 | −2.88 ± 1.21 | −0.29 | 0.693 | −1.76 | 1.19 |
| SEQ (D) | −6.72 ± 4.66 | −2.46 ± 3.14 | −3.56 | 0.013 | −7.54 | −0.99 |
| CCT (μm) | 507.86 ± 62.69 | 525.67 ± 37.54 | −17.81 | 0.399 | −60.58 | 24.96 |
| ECD (cell/mm2) | 2176.76 ± 549.18 | 2257.30 ± 436.12 | −80.54 | 0.686 | −486.95 | 325.86 |
| Polymegathism (%) | 0.37 ± 0.06 | 0.31 ± 0.05 | +0.06 | 0.009 | 0.02 | 0.10 |
| Pleomorphism (%) | 0.48 ± .09 | 0.54 ± 0.10 | −0.06 | 0.139 | −0.13 | 0.02 |
Note: BCVA denotes best corrected visual acuity; SEQ denotes spherical equivalent; CCT denotes central corneal thickness; ECD denotes endothelial cell density.